We are live on ! Find out more
CAPR icon

Capricor Therapeutics
CAPR

22 hedge funds and large institutions have $2.9M invested in Capricor Therapeutics in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more capital invested

Capital invested by funds: $1.75M → $2.9M (+$1.16M)

16% more funds holding

Funds holding: 19 → 22 (+3)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
22
Holders Change
+3
Holders Change %
+15.79%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VKH
Virtu KCG Holdings
New York
+$53.8K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$20.2K
3
UBS Group
UBS Group
Switzerland
+$10.6K
4
FANJ
Financial Architects (New Jersey)
New Jersey
+$7.06K
5
Bank of America
Bank of America
North Carolina
+$106

Top Sellers

1
SM
Sabby Management
Florida
-$70.6K
2
Goldman Sachs
Goldman Sachs
New York
-$8.33K
3
TRCT
Tower Research Capital (TRC)
New York
-$2.4K
4
BFA
BlackRock Fund Advisors
California
-$812
5
Morgan Stanley
Morgan Stanley
New York
-$106
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$719K -$70.6K -2,000 -10%
CBA
2
Coastal Bridge Advisors
Connecticut
$472K – – –
Goldman Sachs
3
Goldman Sachs
New York
$417K -$8.33K -236 -2%
Brown Advisory
4
Brown Advisory
Maryland
$281K – – –
AA
5
Apriem Advisors
California
$280K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$173K – – –
Morgan Stanley
7
Morgan Stanley
New York
$165K -$106 -3 -0.1%
Vanguard Group
8
Vanguard Group
Pennsylvania
$111K +$20.2K +571 +26%
Millennium Management
9
Millennium Management
New York
$73K – – –
BFA
10
BlackRock Fund Advisors
California
$63K -$812 -23 -1%
VKH
11
Virtu KCG Holdings
New York
$60K +$53.8K +1,525 New
HIIFS
12
Harel Insurance Investments & Financial Services
Israel
$27K – – –
PA
13
Perceptive Advisors
New York
$16K – – –
CFN
14
Cordasco Financial Network
Florida
$12K – – –
UBS Group
15
UBS Group
Switzerland
$12K +$10.6K +300 New
FANJ
16
Financial Architects (New Jersey)
New Jersey
$8K +$7.06K +200 New
BA
17
BlackRock Advisors
Delaware
$7K – – –
TRCT
18
Tower Research Capital (TRC)
New York
$3K -$2.4K -68 -47%
BIM
19
BlackRock Investment Management
Delaware
$2K – – –
Bank of America
20
Bank of America
North Carolina
$2K +$106 +3 +6%
GC
21
Globeflex Capital
California
$1K – – –

CAPR Hedge Fund Activity: Q2 2016 in Review

22 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Capricor Therapeutics (CAPR) for Q2 2016, worth a combined $2.9M — up 66% from $1.75M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CAPR positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 5 trimmed.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $53.8K. The largest seller was Sabby Management, cutting an estimated $70.6K.

  • 22 institutional investors held Capricor Therapeutics (CAPR) as of Q2 2016, up from 19 in Q1 2016.
  • Funds reported $2.9M of Capricor Therapeutics stock for Q2 2016, up 66% quarter-over-quarter.
  • 3 funds opened new Capricor Therapeutics positions in Q2 2016 and 0 closed out, a net change of +3 holders.
  • The largest Capricor Therapeutics buyer in Q2 2016 was Virtu KCG Holdings, an estimated $53.8K added.
  • The largest Capricor Therapeutics seller in Q2 2016 was Sabby Management, an estimated $70.6K sold.

Based on aggregated 13F filings for Q2 2016.